Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Akhil Rasim Reddy

Interventional Cardiology Aurora, CO Medical Doctor

NPI 1447644075 CMS profile 4946235

1444 S Potomac St Ste 300, Aurora, CO 80012

Open in the dashboard

General payments

$29,011

205 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Akhil Rasim Reddy of Aurora, CO is reported in the CMS Open Payments database as having received $29,011 across 205 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 80th percentile of Interventional Cardiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,291 29
2024 General $3,612 37
2023 General $17,259 47
2022 General $2,974 35
2021 General $3,628 51
2020 General $217 5
2019 General $29 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Akhil Rasim Reddy
  • Interventional Cardiology median
  • Middle half of Interventional Cardiology
  • National median

In program year 2025, general payments to Akhil Rasim Reddy were reported at $1,291. Among 6,173 Interventional Cardiology profiles paid that year, the median was $1,092 and the middle half received between $366 and $3,019.

Show as a table
Year Akhil Rasim Reddy Interventional Cardiology median Middle half National median
2019 $29 $1,097 $329–$3,048 $163
2020 $217 $473 $161–$1,480 $114
2021 $3,628 $677 $233–$1,827 $132
2022 $2,974 $978 $333–$2,724 $149
2023 $17,259 $1,136 $382–$2,986 $160
2024 $3,612 $1,181 $395–$3,326 $164
2025 $1,291 $1,092 $366–$3,019 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $19,657 77 payments
  2. Edwards Lifesciences Corporation $5,469 54 payments
  3. Abbott Laboratories $1,087 15 payments
  4. Boston Scientific Corporation $685 19 payments
  5. Penumbra, Inc. $387 3 payments
  6. Inari Medical, Inc. $360 3 payments
  7. AstraZeneca Pharmaceuticals LP $279 6 payments
  8. Shockwave Medical, Inc $206 1 payment
  9. Abiomed $170 4 payments
  10. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $157 2 payments
  11. Other $554 21 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Grant $13,000 1 payment
  2. Travel and Lodging $9,109 55 payments
  3. Food and Beverage $6,702 145 payments
  4. Education $200 4 payments
Products named General payments · program years 2019–2025
  1. COREVALVE EVOLUT R $14,279 13 payments
  2. Resolute $2,483 19 payments
  3. EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) $2,157 28 payments
  4. RESOLUTE ONYX $1,916 15 payments
  5. PASCAL $1,441 8 payments
  6. MITRACLIP $828 8 payments
  7. Onyx $504 12 payments
  8. Indigo System $387 3 payments
  9. CT THROMBECTOMY SYSTEM KIT $360 3 payments
  10. FLOWTRIEVER CATHETER, S $360 3 payments
  11. Other $2,930 86 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 3 drugs

Part D claims

44

Median for Interventional Cardiology: 2,236

Drug cost

$282

Median for Interventional Cardiology: $380,412

Branded share of claims

0%

Median for Interventional Cardiology: 27.8%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Potassium Chloride Generic 12 $154
Atorvastatin Calcium Generic 19 $108
Lisinopril Generic 13 $19

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 4,694 Part D prescribers listed as Interventional Cardiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 39 billing codes

Paid by Medicare

$23,986

Medicare's payments for the services billed

Medicare patients

162

Average age 75

Services billed

354

80 women, 82 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 54%
Ischemic heart disease 50%
Atrial fibrillation 43%
Heart failure 38%
Diabetes 35%
Chronic kidney disease 35%
Depression 29%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
WAINUA
  • AstraZeneca Pharmaceuticals LP $20
$20 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

205 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Interventional Cardiology in Colorado

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record